Auteurs Tomic T, Botton T, Cerezo M, Robert G, Luciano F, Puissant A, Gounon P, Allegra M, Bertolotto C, Bereder JM, Tartare-Deckert S, Bahadoran P, Auberger P, Ballotti R, Rocchi S
Cell death & disease Sep 2011
BRCA1 is a new MITF target gene.Auteurs Beuret L, Ohanna M, Strub T, Allegra M, Davidson I, Bertolotto C, Ballotti R
Pigment cell & melanoma research Aug 2011
Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).Auteurs Ohanna M, Giuliano S, Bonet C, Imbert V, Hofman V, Zangari J, Bille K, Robert C, Bressac-de Paillerets B, Hofman P, Rocchi S, Peyron JF, Lacour JP, Ballotti R, Bertolotto C
Genes & development Juin 2011
SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.Auteurs Fenouille N, Puissant A, Tichet M, Zimniak G, Abbe P, Mallavialle A, Rocchi S, Ortonne JP, Deckert M, Ballotti R, Tartare-Deckert S
Oncogene Juin 2011
Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.Auteurs Strub T, Giuliano S, Ye T, Bonet C, Keime C, Kobi D, Le Gras S, Cormont M, Ballotti R, Bertolotto C, Davidson I
Oncogene May 2011
Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.Auteurs Cheli Y, Giuliano S, Guiliano S, Botton T, Rocchi S, Hofman V, Hofman P, Bahadoran P, Bertolotto C, Ballotti R
Oncogene Jan 2011
The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.Auteurs Fenouille N, Robert G, Tichet M, Puissant A, Dufies M, Rocchi S, Ortonne JP, Deckert M, Ballotti R, Tartare-Deckert S
Pigment cell & melanoma research Nov 2010
GLI2-mediated melanoma invasion and metastasis.Auteurs Alexaki VI, Javelaud D, Van Kempen LC, Mohammad KS, Dennler S, Luciani F, Hoek KS, Juàrez P, Goydos JS, Fournier PJ, Sibon C, Bertolotto C, Verrecchia F, Saule S, Delmas V, Ballotti R, Larue L, Saiag P, Guise TA, Mauviel A
Journal of the National Cancer Institute Aug 2010
Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth.Auteurs Botton T, Puissant A, Cheli Y, Tomic T, Giuliano S, Fajas L, Deckert M, Ortonne JP, Bertolotto C, Tartare-Deckert S, Ballotti R, Rocchi S
Cell death and differentiation Juil 2010
Functional role of MITF phosphorylation. In vivo veritas?Auteurs Bertolotto C, Ballotti R
Pigment cell & melanoma research Dec 2009